Sign In
Buy HBIO
$6.50
+0.0400 (+0.619%)
At Close: Jun 03, 2026
Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023
04:40pm, Monday, 20'th Nov 2023
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Con
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
04:30pm, Thursday, 09'th Nov 2023
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwe
Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript
02:08pm, Tuesday, 07'th Nov 2023
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting James Green - Cha
Harvard Bioscience Announces Third Quarter 2023 Financial Results
07:00am, Tuesday, 07'th Nov 2023
HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2023.
HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (S
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
09:00am, Monday, 30'th Oct 2023
HOLLISTON, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2023 before the market opens on Nove
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)
Harvard Bioscience: Looking To Reload After Post-Q2 Earnings Sell-Off
07:54am, Thursday, 07'th Sep 2023
Harvard Bioscience's Q2 earnings showed a slight miss on EPS and revenue, causing a decline in the stock price. The company is committed to improving its product portfolio and has observed increased t
Harvard Bioscience, Inc. (HBIO) Q2 2023 Earnings Call Transcript
01:55pm, Tuesday, 08'th Aug 2023
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2023 Earnings Conference Call August 8, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting James Green - Chair
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
10:40am, Tuesday, 08'th Aug 2023
Harvard Bioscience (HBIO) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
06:30pm, Thursday, 03'rd Aug 2023
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
06:36pm, Thursday, 27'th Jul 2023
HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8,
Here's Why Momentum in Harvard Bioscience (HBIO) Should Keep going
10:19am, Wednesday, 21'st Jun 2023
Harvard Bioscience (HBIO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Harvard Bioscience: Rally In Shares Losing Steam
05:06pm, Tuesday, 20'th Jun 2023
Today, we take our first look at medical device concern Harvard Bioscience, Inc. The shares have doubled over the past few months on better-than-expected results and improving cash flow. Can the rally
3 Instruments Stocks to Watch From a Prospering Industry
10:06am, Friday, 16'th Jun 2023
The Zacks Instruments - Scientific industry participants like Harvard Bioscience (HBIO), Mettler-Toledo (MTD) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-mar
